Literature DB >> 11086554

Clinical suggestions for management of stimulant treatment in adolescents.

M Weiss1, U Jain, J Garland.   

Abstract

Children with attention-deficit hyperactivity disorder (ADHD) do not typically outgrow this condition in adolescence, which is a challenging period of development. Management of ADHD in adolescence requires specific accommodations. These include providing adolescents with as much control over treatment as possible, so that they perceive treatment to be widening their autonomy rather than limiting it. Wherever possible, medication needs to be long-acting to facilitate compliance and to minimize problems with rebound misbehaviour and moodiness. Comorbid psychiatric symptoms and syndromes need to be evaluated carefully both pre- and posttreatment. Ongoing psychoeducation and support can help to restructure the demands that an adolescent with ADHD faces at home and school so that they are more manageable. With active treatment it may be possible to prevent the serious morbidity associated with ADHD during this period and to lay a foundation for adulthood.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11086554     DOI: 10.1177/070674370004500804

Source DB:  PubMed          Journal:  Can J Psychiatry        ISSN: 0706-7437            Impact factor:   4.356


  6 in total

Review 1.  Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge.

Authors:  Yu-Shu Huang; Ming-Horng Tsai
Journal:  CNS Drugs       Date:  2011-07       Impact factor: 5.749

Review 2.  Drug compliance in adolescents: assessing and managing modifiable risk factors.

Authors:  Betty Staples; Terrill Bravender
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

3.  [Long-acting methylphenidate. An alternative medical therapy for adult patients with attention deficit hyperactivity disorder].

Authors:  E Sobanski; B Alm
Journal:  Nervenarzt       Date:  2005-11       Impact factor: 1.214

Review 4.  Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome.

Authors:  Lily Hechtman; Brian Greenfield
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

Review 5.  Compliance with stimulants for attention-deficit/hyperactivity disorder: issues and approaches for improvement.

Authors:  James Swanson
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

6.  Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia.

Authors:  Jihyung Hong; Diego Novick; Tamás Treuer; William Montgomery; Virginia S Haynes; Shenghu Wu; Josep Maria Haro
Journal:  Patient Prefer Adherence       Date:  2013-09-30       Impact factor: 2.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.